meditip

CDMO Operation Consulting Overview

To secure investigational drug production and approval documentation, we provide integrated support for process, testing methods, and GMP technology transfer strategies based on a full-lifecycle Quality Management System (QMS).

Through this, we minimize the risks and costs across CDMO operations, providing an environment where developers can focus on clinical strategy and enhancing product value.

• 
  Optimal Cost

  We reduce fixed costs for production and quality operations, enabling development resources to focus on clinical strategy and core value creation.

• 
  Shortened Development Timeline

  Through process optimization and CDMO operation strategy, we minimize development schedule risks and support rapid clinical entry.

• 
  QMS-Based Operation

  Based on a full-lifecycle quality management system, we secure data reliability and development continuity to provide a stable development environment.

• 
  GMP Technology Transfer

  Through GMP technology transfer strategy, we build a stable production system and secure the efficiency and quality consistency of CDMO operations.

QMS-Based Quality Management System

In an environment of increasingly demanding regulatory requirements, we support the establishment of a full-lifecycle QMS that reflects the complex quality characteristics of biopharmaceuticals.

In particular, through a systematic quality management system that can evaluate and maintain product comparability based on change management, we help ensure consistent quality from development to production.

Development Efficiency Through CDMO Operation Innovation

Meditip comprehensively improves fragmented CDMO operation structures to minimize cost, schedule, and quality risks.

Free from complex operations, you can focus on clinical trial design and execution and on enhancing product and corporate value.